Equities

Viracta Therapeutics Inc

Viracta Therapeutics Inc

Actions
  • Price (USD)0.2161
  • Today's Change-0.007 / -3.05%
  • Shares traded183.56k
  • 1 Year change-84.78%
  • Beta0.7254
Data delayed at least 15 minutes, as of Aug 30 2024 19:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade Viracta Therapeutics Inc (VIRX:NAQ) traded at 0.2161, 6.98% above its 52-week low of 0.202, set on Aug 27, 2024.
52-week range
Today
0.202Aug 27 20241.52Sep 01 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.2162
High0.2224
Low0.205
Bid0.213
Offer0.2191
Previous close0.2229
Average volume664.15k
Shares outstanding39.42m
Free float38.29m
P/E (TTM)--
Market cap8.79m USD
EPS (TTM)-1.16
USD
Data delayed at least 15 minutes, as of Aug 30 2024 19:00 BST.
More ▼

Events & Activity

  • VIRX:NAQ price reached a new 52-week low of 0.255 at 10:31 BST
  • VIRX:NAQ price reached a new 52-week low of 0.2659 at 14:51 BST
  • VIRX:NAQ trading volume exceeds daily average by +45.39%
  • VIRX:NAQ price moved over +2.91% to 0.29
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.